STIM Aug 2022 7.500 call
| Previous Close | 0.1000 |
| Open | 0.1000 |
| Bid | 0.0000 |
| Ask | 1.0000 |
| Strike | 7.50 |
| Expire Date | 2022-08-19 |
| Day's Range | 0.1000 - 0.1000 |
| Contract Range | N/A |
| Volume | |
| Open Interest | 7 |
- Simply Wall St.
Neuronetics (NASDAQ:STIM) investors are sitting on a loss of 82% if they invested a year ago
The art and science of stock market investing requires a tolerance for losing money on some of the shares you buy. But...
- GlobeNewswire
Neuronetics to Present at the William Blair 42nd Annual Growth Stock Conference
MALVERN, Pa., May 25, 2022 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial-stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurological health disorders, today announced that Keith Sullivan, President and Chief Executive Officer, and Steve Furlong, Senior Vice President, Chief Financial Officer, and Treasurer will present at the William Blair 42nd Annual Growth Stock Confere
- GlobeNewswire
New Peer-Reviewed Data Continue to Further Best Practices with NeuroStar® Advanced Therapy
Published in Brain Stimulation Journal, study describes insights from world’s largest depression registry MALVERN, Pa., May 17, 2022 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial-stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurological health disorders, announced today a new peer-reviewed paper, published in Brain Stimulation Journal and available online now. The paper
